Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Julphar
US Department of Justice
Farmers Insurance
AstraZeneca
Boehringer Ingelheim
Harvard Business School
QuintilesIMS
Federal Trade Commission
Novartis

Generated: October 21, 2017

DrugPatentWatch Database Preview

Apopharma Inc Company Profile

« Back to Dashboard

What is the competitive landscape for APOPHARMA INC, and when can generic versions of APOPHARMA INC drugs launch?

APOPHARMA INC has two approved drugs.

There are two US patents protecting APOPHARMA INC drugs on APOPHARMA INC drugs in the past three years.

There are thirty-seven patent family members on APOPHARMA INC drugs in twenty-four countries.

Summary for Applicant: Apopharma Inc

International Patents:37
US Patents:2
Tradenames:1
Ingredients:1
NDAs:2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apopharma Inc
FERRIPROX
deferiprone
TABLET;ORAL021825-001Oct 14, 2011RXYesYes► Subscribe► Subscribe► Subscribe
Apopharma Inc
FERRIPROX
deferiprone
TABLET;ORAL021825-001Oct 14, 2011RXYesYes► Subscribe► Subscribe► Subscribe
Apopharma Inc
FERRIPROX
deferiprone
SOLUTION;ORAL208030-001Sep 9, 2015RXYesYes► Subscribe► Subscribe► Subscribe
Apopharma Inc
FERRIPROX
deferiprone
SOLUTION;ORAL208030-001Sep 9, 2015RXYesYes► Subscribe► Subscribe► Subscribe
Apopharma Inc
FERRIPROX
deferiprone
TABLET;ORAL021825-001Oct 14, 2011RXYesYes► Subscribe► Subscribe ► Subscribe
Apopharma Inc
FERRIPROX
deferiprone
SOLUTION;ORAL208030-001Sep 9, 2015RXYesYes► Subscribe► Subscribe ► Subscribe
Apopharma Inc
FERRIPROX
deferiprone
SOLUTION;ORAL208030-001Sep 9, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for APOPHARMA INC drugs

Drugname Dosage Strength Tradename Submissiondate
deferiprone
Tablets500 mg
FERRIPROX
1/29/2016

International Patent Family for Apopharma Inc Drugs

Country Document Number Estimated Expiration
Hong Kong1130422► Subscribe
Cyprus1116146► Subscribe
Australia2001270402► Subscribe
Spain2539414► Subscribe
European Patent Office2268282► Subscribe
Australia7040201► Subscribe
Eurasian Patent Organization201071235► Subscribe
Hong Kong1152871► Subscribe
Costa Rica11744► Subscribe
Australia2008355464► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Healthtrust
Dow
US Department of Justice
Covington
Federal Trade Commission
Teva
Colorcon
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot